HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Hematology
Sys. Review
Siltuximab shows partial response in two iMCD-IPL cases with xanthelasma; skin lesions unchanged
Two patients with rare Castleman disease had xanthelasma that did not improve with treatment.
A case report describes two Asian women in their 5th decade with idiopathic plasmacytic lymphadenopathy subtype of idiopathic multicentric C…
Two women with rare Castleman disease saw their skin inflammation improve but stubborn yellow eyelid patches stayed despite treatment.
Frontiers
Apr 1, 2026
Hematology
Perspective highlights diagnostic overlap between idiopathic multicentric Castleman disease and systemic lupus erythematosus
Castleman disease can resemble lupus, requiring careful diagnosis for proper treatment
A perspective article discusses the clinical resemblance between idiopathic multicentric Castleman disease (iMCD) and systemic lupus erythem…
Castleman disease often mimics lupus with shared symptoms and autoantibodies, but misdiagnosis risks wrong treatment until a lymph node biop…
Frontiers
Mar 31, 2026